Hypertension in a patient with aldosterone deficiency

Endocrine Practice

Volumn 11, Issue 2, 2005, Pages 104-107

  Touger, Leslie ^a   Joseph, Mark ^a   Hasan, Khalid S ^a  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUDROCORTISONE; POTASSIUM; RENIN; SODIUM; SODIUM CHLORIDE;

ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BREAST FEEDING; CASE REPORT; CHEMOLUMINESCENCE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG MECHANISM; FAILURE TO THRIVE; FEMALE; FEMALE GENITAL SYSTEM; FLUID THERAPY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOALDOSTERONISM; HYPONATREMIA; HYPOVOLEMIA; IMMUNOCHEMISTRY; INFANT; POTASSIUM BLOOD LEVEL; QUANTITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BLOOD LEVEL; VASOCONSTRICTION;

EID: 18744412375     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.11.2.104     Document Type: Article

References (16)

1. Yanagibashi K, Haniu M, Shively JE, Shen WH, Hall P. The synthesis of aldosterone by the adrenal cortex: two zones (fasciculata and glomerulosa) possess one enzyme for 11 beta-, 18-hydroxylation, and aldehyde synthesis. J Biol Chem. 1986;261:3556-3562.
2. Rosler A, Rabinowitz D, Theodor R, Ramirez LC, Ulick S. The nature of the defect in a salt-wasting disorder in Jews of Iran. J Clin Endocrinol Metab. 1977;44:279-291.
3. White PC. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am. 2001;30:61-79, vi.
4. Ulick S. Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway. J Clin Endocrinol Metab. 1976;43:92-96.
5. Peter M, Fawaz L, Drop SL, Visser HK, Sippell WG. Hereditary defect in biosynthesis of aldosterone: aldosterone synthase deficiency 1964-1997. J Clin Endocrinol Metab. 1997;82:3525-3528.
6. Portrat-Doyen S, Tourniaire J, Richard O, et al. Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene. J Clin Endocrinol Metab. 1998;83:4156-4161.
7. Zhang G, Rodriguez H, Fardella CE, Harris DA, Miller WL. Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency. Am J Hum Genet. 1995;57: 1037-1043.
8. Fardella CE, Hum DW, Rodriguez H, et al. Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency. J Clin Endocrinol Metab. 1996;81:321-326.
9. Kayes-Wandover KM, Tannin GM, Shulman D, et al. Congenital hyperreninemic hypoaldosteronism unlinked to the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab. 2001;86:5379-5382.
10. Lashansky G, Saenger P, Fishman K, et al. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab. 1991;73: 674-686.
11. Lashansky G, Saenger P, Dimartino-Nardi J, et al. Normative data for the steroidogenic response of mineralocorticoids and their precursors to adrenocorticotropin in a healthy pediatric population. J Clin Endocrinol Metab. 1992;75:1491-1496.
12. Peter M, Partsch CJ, Sippell WG. Multisteroid analysis in children with terminal aldosterone biosynthesis defects. J Clin Endocrinol Metab. 1995;80:1622-1627.
13. Miller WL. The adrenal cortex. In: Sperling M, ed. Pediatric Endocrinology. 2nd ed. New York, NY: Elsevier Sciences, WB Saunders, 2002: 385-438.
14. Rodriguez-Soriano J. Tubular disorders of electrolyte regulation. In: Barratt TM, Avner ED, Harmon WE, eds. Pediatric Nephrology. Baltimore, MD: Lippincott Williams & Wilkins, 1999: 545-563.
15. Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens. 1999;12(12 Pt 3):205S-213S.
16. Guillery EN, Robillard JE. The renin-angiotensin system and blood pressure regulation during infancy and childhood. Pediatr Clin North Am. 1993;40:61-79.